ImmunisLogoWImmunisLogoImmunis Chairman Dr. Hans Keirstead Delivered Keynote at the Aging and Gerontology Conference in Dubai [video]Immunis Chairman Dr. Hans Keirstead Delivered Keynote at the Aging and Gerontology Conference in Dubai [video]
  • Home
  • About
  • Technology
  • Clinical Trials
  • News & Media
  • Contact
✕
Immunis Chairman Dr. Hans Keirstead Presents at the Rejuvenation Startup Summit in Berlin [photos]
Immunis Chairman Dr. Hans Keirstead Meets With His Holiness the Dalai Lama [photos]
Immunis Chairman Dr. Hans Keirstead Delivered Keynote at the Aging and Gerontology Conference in Dubai [video]
IRVINE, Calif. — October 24, 2022 — Immunis Inc. Chairman, Dr. Hans Keirstead, presented a keynote at the 2022 Aging and Gerontology Conference in Dubai. Please enjoy the video footage of his keynote.

About Aging and Gerontology Conference

The Aging and Gerontology conference is focused on cellular & molecular repair of age-associated disease. The conference strives to help medical professionals in the geriatric field and the public to understand, empathize and take action to aid the individuals worldwide. For additional information about the Aging and Gerontology Conference please visit: www.agingcongress.com

 About Immunis Inc.

Immunis is a private biotechnology company developing a novel immunomodulatory secretome product for the various manifestations of age and disease-related immune decline. The STEM product line leverages Immunis’ leading-edge capabilities in stem cell technologies to deliver a product of all natural, all human immune modulators in their natural relative physiological concentrations. For additional information about Immunis’ IMM01-STEM Phase 1/2a trial please visit: www.immunisbiomedical.com

###

Share

Recent News

  • Jan 26, 2023

    Immunis Chairman Dr. Hans Keirstead to Present at 2023 BIO CEO and Investor Conference

  • Jan 24, 2023

    Immunis Recruits Individuals with Muscle Atrophy for Phase 1/2a Clinical Trial

  • Jan 16, 2023

    Immunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis Research

Navigation

  • Home
  • About
  • Technology
  • Clinical Trials
  • News & Media
  • Contact

Contact info

Immunis, Inc.
Irvine, California


contact@immunisbiomedical.com

© 2022 Immunis, Inc. | All Rights Reserved